SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001193125-24-102947
Filing Date
2024-04-19
Accepted
2024-04-19 16:30:15
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B3 d830350d424b3.htm 424B3 411068
2 GRAPHIC g830350g0418080114813.jpg GRAPHIC 3832
  Complete submission text file 0001193125-24-102947.txt   417693
Mailing Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000
Business Address THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 01161298780088
KAZIA THERAPEUTICS LTD (Filer) CIK: 0001075880 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 424B3 | Act: 33 | File No.: 333-276774 | Film No.: 24858202
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)